Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis.

导出 OA

翻译打印收藏纠错

第一作者： Ryosuke,Fukuda

第一单位： Department of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, 2-1 Gakuen, Sanda, Hyogo 669-1337, Japan.

作者： Ryosuke,Fukuda ^[1] ; Tsukasa,Okiyoneda ^[1]

作者单位： Department of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, 2-1 Gakuen, Sanda, Hyogo 669-1337, Japan. ^[1]

关键词 chaperone cystic fibrosis (CF) treatment cystic fibrosis transmembrane conductance regulator (CFTR)endoplasmic reticulum quality control (ERQC)plasma membrane quality control (PMQC)ubiquitylation

DOI 10.3390/ph13040075

PMID 32331485

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceuticals (Basel, Switzerland)

2020年13卷4期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史清除